In a filing, Centessa Pharmaceuticals plc ADR revealed its Chief People Officer Anderson Karen M. unloaded Company’s shares for reported $0.58 million on Feb 07 ’25. In the deal valued at $19.03 per share,30,526 shares were sold. As a result of this transaction, Anderson Karen M. now holds 54,322 shares worth roughly $0.97 million.
Then, Anderson Karen M. sold 429 shares, generating $8,147 in total proceeds. Upon selling the shares at $18.99, the Chief People Officer now owns 54,322 shares.
Before that, Anderson Karen M. bought 429 shares. Centessa Pharmaceuticals plc ADR shares valued at $8,147 were divested by the Officer at a price of $18.99 per share.
TD Cowen initiated its Centessa Pharmaceuticals plc ADR [CNTA] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid September from “an Equal-weight” to “an Overweight”. B. Riley Securities began covering CNTA with “Buy” recommendation on September 19, 2024. Oppenheimer started covering the stock on July 18, 2024. It rated CNTA as “an Outperform”.
Price Performance Review of CNTA
On Monday, Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] saw its stock fall -6.52% to $17.79. Over the last five days, the stock has gained 5.27%. Centessa Pharmaceuticals plc ADR shares have risen nearly 6.21% since the year began. Nevertheless, the stocks have risen 135.01% over the past one year. While a 52-week high of $19.09 was reached on 02/07/25, a 52-week low of $7.38 was recorded on 01/14/25. SMA at 50 days reached $16.88, while 200 days put it at $13.44.
Levels Of Support And Resistance For CNTA Stock
The 24-hour chart illustrates a support level at 16.76, which if violated will result in even more drops to 15.74. On the upside, there is a resistance level at 18.90. A further resistance level may holdings at 20.02. The Relative Strength Index (RSI) on the 14-day chart is 56.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.19, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 36.31%. Stochastics %K at 84.50% indicates the stock is a selling.
How much short interest is there in Centessa Pharmaceuticals plc ADR?
A steep rise in short interest was recorded in Centessa Pharmaceuticals plc ADR stocks on 2025-01-15, dropping by -0.34 million shares to a total of 3.29 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 3.63 million shares. There was a decline of -10.44%, which implies that there is a negative sentiment for the stock.
